(Q38704457)

5 September 2017

1 reference

title

Efficacy and tolerability of simvastatin (MK-733). (English)

1 reference

5 September 2017

1 reference

Stalenhoef AF

1

1 reference

5 September 2017

Mol MJ

series ordinal

2

1 reference

5 September 2017

Stuyt PM

series ordinal

3

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

American Journal of Medicine

5 September 2017

published in

1 reference

5 September 2017

volume

87

1 reference

5 September 2017

issue

4A

1 reference

5 September 2017

page(s)

39S-43S

1 reference

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Current pharmacologic treatment of elevated serum cholesterol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Cholesterol synthesis inhibitors in hyperlipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980597-2

10.1016/S0002-9343(89)80597-2

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference